Clinical Trial Update: Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for Inflammation and Depression Following SCI [NA]

View source ↗

Summary

This clinical trial is evaluating transcutaneous auricular vagus nerve stimulation (taVNS) to reduce inflammation and depression in people with spinal cord inju…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Spinal Cord Injury

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Spinal Cord Injury, Depression | NA | Status: RECRUITING